Introduction
The importance of identifying and treating gestational diabetes is increasingly being recognized. Even mild gestational diabetes, which can be treated successfully by dietary measures or small doses of insulin, may without treatment become complicated by increased perinatal morbidity and mortality. '4 Nevertheless, the cause of impaired glucose tolerance during gestation is unknown.
It has long been known that during gestation tryptophannicotinic acid metabolism needs more of the rate-limiting coenzyme pyridoxal phosphate. Consequently, nearly every pregnant woman will develop a relative pyridoxine deficiency, as shown by an increased urinary excretion of tryptophan metabolites, particularly xanthurenic acid, 5 6after oral administration of L-tryptophan ( fig. 1 ). The increased need for pyridoxal phosphate is met by oral administration of vitamin B6, after which xanthurenic-acid excretion after an oral load of Ltryptophan becomes normal.6 7 In animal experiments xanthurenic acid has a diabetogenic effect. 17 In a 27-year-old woman (para 2, gravida 3) a disturbed glucose tolerance was found after 29 weeks' amenorrhoea ( fig. 2 A) 6 But the well-known changes which occur in tryptophan-nicotinic acid metabolism during pregnancy5 6 7 and which increase the excretion of the diabetogenic insulin antagonist xanthurenic acid8 17 18 have never been related to the pathogenesis of gestational diabetes. In our 14 patients with gestational diabetes 13 showed an increased xanthurenic-acid excretion after an oral load of L-tryptophan, which indicated at least a relative pyridoxine deficiency, and eight patients had abnormally low blood vitamin B6 levels. Blood vitamin B6 levels in pregnancy are known to be reduced or deficient towards the end of gestation,'9 but oral vitamin B6 treatment over two weeks (100 mg/day) restored the vitamin B6 status of all 13 deficient patients to normal. The glucose tolerance also improved significantly even though pregnancy had advanced about four weeks and a further deterioration of oral glucose tolerance was to have been expected.14 In our laboratory dietary measures have a negligible effect on the standardized oral glucose tolerance test. The decreases in the mean fasting and two-hour values were especially important because these values are generally thought to be the most significant ones.
In conclusion, tryptophan-nicotinic acid metabolism obviously becomes unbalanced in pregnant patients with gestational diabetes. When this balance was restored by oral administration of vitamin B6 the increased excretion of the diabetogenic metabolite xanthurenic acid became normal in our patients, while their oral glucose tolerance improved. Xanthurenic acid may act as an insulin antagonist during pregnancy and sometimes cause gestational diabetes. Adaptation of insulin production and release to increasing synthesis of an insulin antagonist during pregnancy may determine whether or not a disturbance in the glucose tolerance will result. Nevertheless, it remains to be proved whether there is a relation between xanthurenic acid and gestational diabetes. Oral administration of vitamin B6 certainly improves significantly the oral glucose tolerance in gestational diabetes, but it is most important to know whether vitamin B6 given prophylactically could have a long-term influence by preventing the development of gestational diabetes during pregnancy.
Diabetic autonomic neuropathy may have widespread consequences, and many abnormalities of the peripheral vascular system have been described. 14 Defective autonomic control ofthe heart has received much less study. Our aim was to discover whether cardiac efferent nerves are involved in diabetic neuropathy and see how far such abnormalities might account for defective cardiovascular reflexes.
Methods
Thirteen patients who showed severe diabetic complications, including features of autonomic neuropathy, were studied (see After each of these tests the pulse rate and blood pressure were allowed to return as near to control levels as possible before the next test was carried out.
Propranolol.-A 10 mg dose of propranolol was given slowly intravenously to block sympathetic stimulation of the heart.
Atropine.-Atropine 1-8 mg was given intravenously about 30 minutes after propranolol to block vagal stimulation of the heart.
Lobeline.-On the same or a different day eight patients were given 6 mg lobeline by rapid intravenous injection to test chemoreceptor reflex pathways.
Results
Basal Heart Rate.-In three patients the resting heart rate was over 95/min, and in six it was 85 or more per min ( fig. 1) .
Beat-to-beat variation (sinus arrhythmia) of the heart rate on deep breathing was normal in only one patient, all the others showing variations of 7 or less per min, mostly 3 or less per min. The normal beat-to-beat variation in adults under 50 years of age is always greater than 10/min.5
